Found 0 matching trials
Ensartinib, Carboplatin, Pemetrexed and Bevacizumab for the Treatment of Stage IIIC or IV or Recurrent ALK-Positive Non-small Cell Lung Cancer
PHASE1This phase Ib trial finds the best dose and side effects of ensartinib and ...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Ex VIvo DEtermiNed Cancer Therapy
N/AEVIDENT's aim is to test if ex vivo drug screening can predict whether pati...
Location
Sheffield Teaching Hospitals NHS Foundation Trust
Resiliency in Older Adults Undergoing Bone Marrow Transplant
N/AThe objective of this research is to measure certain indicators of resilien...
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Safety and Efficacy of CT125A Cells for Treatment of Relapsed/Refractory CD5+ Hematopoietic Malignancies
EARLY_PHASE1Current treatments for relapsed/refractory hematopoietic malignancies such ...
Location
Multiple Locations
Stereotactic Body Radiation Therapy for Inoperable Locally-advanced Non-small Cell Lung Cancer
PHASE1The purpose of this study is to determine if the use of exploratory immunol...
Location
Memorial Sloan Kettering Cancer Center at Basking Ridge
NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders
PHASE2RATIONALE: Giving low doses of chemotherapy before a donor peripheral blood...
Location
Roswell Park Cancer Institute
A Study of TRC105 in Combination With Paclitaxel/Carboplatin and Bevacizumab in Non-Squamous Cell Lung Cancer
PHASE1This is a single center, open-label, nonrandomized, phase 1b study of TRC10...
Location
UAB Comprehensive Cancer Center
Study on AI-assisted Multimodal Diagnosis System of Autoimmune Pancreatitis
N/AThe existing comprehensive diagnostic system for autoimmune pancreatitis (A...
Location
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Response Adaptive Radiotherapy Following Immunotherapy-based Induction for Non-HPV Related HNSCC
PHASE2The aim of this study is to develop an adaptive radiation therapy plan for ...
Location
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, CAMS & PUMC
Thymalfasin-based PRaG Mode for Advanced Refractory Solid Tumors
PHASE2This is an open-label, single-arm, Phase II investigator-initiated trial of...
Location
The Second Affiliated Hospital of SchoowUniversity